Catalase and paraoxonase in hypertensive type 2 diabetes mellitus:: Correlation with glycemic control

被引:40
作者
Sözmen, B
Delen, Y
Girgin, FK
Sözmen, EY
机构
[1] Department of Internal Medicine, Atatürk State Hospital, Izmir
[2] Department of Biochemistry, Ege University Faculty of Medicine, Izmir
关键词
type 2 diabetes mellitus; hypertension; catalase; superoxide dismutase; paraoxonase;
D O I
10.1016/S0009-9120(99)00034-X
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Objectives: Type 2 diabetes mellitus (DM) is well recognized as being associated with increased prevalence of hypertension. Experimental and epidemiologic studies have shown that oxygen-free radicals are elevated because antioxidant enzyme activities are altered both in uncontrolled essential hypertension and DM itself. Recently paraoxonase (PON) has been recognized as an antioxidant enzyme that hydrolyzes lipid peroxides. The aim of this study is to evaluate simultaneously PON activities and antioxidant status in hypertensive type 2 DM cases and to establish any possible relationship between these parameters and duration of hypertension or diabetes, hemoglobin (Hb) A(1c) levels, and lipid parameters. Design and methods: Nineteen normotensive subjects with type 2 DM, 37 hypertensive (diastolic blood pressure 90 mm Hg or more) subjects with type 2 DM, and 25 normotensive control subjects with normal glucose tolerance were selected for this study. Superoxide dismutase (SOD), catalase, and basal-stimulated PON activities were measured by the methods of Sun et al.; Goth; and Eckerson, Wyte, and La Du, respectively; other lipid parameters were determined using an autoanalyzer. Results: Catalase activities of either hypertensive patients with type 2 DM or type 2 DM patients without complication were found to be higher than controls (p < 0.01), although no significant difference in SOD and basal-stimulated PON activities was observed between these groups. A significant elevation in catalase activity (p = 0.004) of patients with high HbA(1c) levels (>7.0%) (n = 37) compared with patients with low HbA(1c) levels (<7.0%) (n = 19) was detected. There was also a positive correlation between the catalase activities and fasting glucose levels and HbA(1c) concentrations in hypertensive patients with type 2 DM (r = 0.4567, p < 0.05 and r = 0.3686, p < 0.05, respectively). An increase in catalase activity of patients with B and/or AB phenotype compared with patients with A phenotype was also noted. Conclusion: Poor glycemic control in diabetes is strongly associated with an increase in free radicals and consequent diabetic complications. Uncontrolled glucose metabolism may also be the cause of alterations in antioxidant enzymes. Among these; catalase correlates best with poor glycemic control. The current data reveal that B allele carriers of PON are more susceptible to oxidant stress. Copyright (C) 1999 The Canadian Society of Clinical Chemists.
引用
收藏
页码:423 / 427
页数:5
相关论文
共 21 条
[1]   The Gln-Arg191 polymorphism of the human paraoxonase gene (HUMPONA) is not associated with the risk of coronary artery disease in Finns [J].
Antikainen, M ;
Murtomaki, S ;
Syvanne, M ;
Pahlman, R ;
Tahvanainen, E ;
Jauhiainen, M ;
Frick, MH ;
Ehnholm, C .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (04) :883-885
[2]   INCREASE IN THE GLUCOSYLATED FORM OF ERYTHROCYTE CU-ZN-SUPEROXIDE DISMUTASE IN DIABETES AND CLOSE ASSOCIATION OF THE NONENZYMATIC GLUCOSYLATION WITH THE ENZYME-ACTIVITY [J].
ARAI, K ;
IIZUKA, S ;
TADA, Y ;
OIKAWA, K ;
TANIGUCHI, N .
BIOCHIMICA ET BIOPHYSICA ACTA, 1987, 924 (02) :292-296
[3]   ROLE OF OXIDATIVE STRESS IN DEVELOPMENT OF COMPLICATIONS IN DIABETES [J].
BAYNES, JW .
DIABETES, 1991, 40 (04) :405-412
[4]  
DZAU VJ, 1990, J CARDIOVASC PHAR S5, V15, P59
[5]  
ECKERSON HW, 1983, AM J HUM GENET, V35, P1126
[6]  
FERRISS JB, 1991, J HUM HYPERTENS, V5, P245
[7]  
FREEMAN BA, 1982, LAB INVEST, V47, P412
[8]   A SIMPLE METHOD FOR DETERMINATION OF SERUM CATALASE ACTIVITY AND REVISION OF REFERENCE RANGE [J].
GOTH, L .
CLINICA CHIMICA ACTA, 1991, 196 (2-3) :143-151
[9]   Paraoxonase-2 gene (PON2) G148 variant associated with elevated fasting plasma glucose in noninsulin-dependent diabetes mellitus [J].
Hegele, RA ;
Connelly, PW ;
Scherer, SW ;
Hanley, AJG ;
Harris, SB ;
Tsui, LC ;
Zinman, B .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (10) :3373-3377
[10]   Paraoxonase as a risk marker for cardiovascular disease: Facts and hypotheses [J].
Laplaud, PM ;
Dantoine, T ;
Chapman, MJ .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 1998, 36 (07) :431-441